Thanks, Chad. Before I review our third quarter results and also our outlook for the fourth quarter and full year 2017, I would like to remind everyone that my comments related to certain financial measures will be on a non-GAAP basis. We use adjusted EBITDA and non-GAAP net income as supplemental measures to review and assess our performance and for planning purposes. Adjusted EBITDA is a non-GAAP financial measure that excludes non-cash stock-based compensation expense. Non-GAAP net income is a non-GAAP financial measure that also reflects adjustment for non-cash stock-based compensation expense, which is further adjusted for the effective income taxes. Reconciliations of the GAAP to non-GAAP measures discussed today are included in the earnings press release issued earlier this afternoon. As Chad mentioned, we had good results in the third quarter with total revenues of 101.3 million, representing year-over-year growth of 31% from the comparable prior year period. Our revenue growth continues to be primarily driven by new business wins, and we are pleased with our continued performance over the comparable growth we saw in 2016. Within total revenues, recurring revenue was 99.5 million for the third quarter of 2017, representing 98% of total revenues for the quarter and growing 31% from the comparable prior year period. Total adjusted gross profit for the third quarter was 85 million, representing an adjusted gross margin of 84%. For the full year 2017, we anticipate that our adjusted gross margin will be within a range of 83% to 84%. Total adjusted administrative expenses were 59.3 million for the quarter as compared to 49.1 million in the third quarter of 2016. Adjusted sales and marketing expense for the third quarter of 2017 was 33.5 million. Adjusted R&D was 7.4 million in the third quarter of 2017 or 7.3% of total revenues. Although, we capitalized a higher percentage of total R&D costs this quarter, we anticipate going forward our capitalize R&D costs will be in line with our historical capitalization rate of approximately 29% to 32% that we may see fluctuations from quarter-to-quarter. Total adjusted R&D costs including the capitalize portion were 10.8 million in the third quarter of 2017, compared to 7.6 million in the prior year period. Adjusted EBITDA was 30.7 million or 30.3% of total revenues in the third quarter of 2017, compared to 18.2 million or 23.5% of total revenues in the third quarter of 2016. Our GAAP net income for the third quarter was $14.1 million or $0.24 per diluted share, based on approximately 59 million shares versus 6.2 million or $0.10 per diluted share based on approximately 59 million shares a year ago. Our effective income tax rate for the third quarter year-to-date 2017 was 8.3%. Non-GAAP net income for the third quarter of 2017 was $17 million or $0.29 per diluted share based on approximately 59 million shares versus $9 million or $0.15 per diluted share a year ago. We expect stock-based comp to be approximately $7 million in the fourth quarter of 2017. In the second quarter, we repurchased a total of approximately $17.3 million of stock under our $50 million share repurchase plan. As Chad mentioned, we are pleased to announce our $75 million repurchase plan and look forward to continuing to return cash to our stockholders opportunistically via open market purchases. For modeling purposes, we anticipate fully diluted shares outstanding will be approximately 59 million in the fourth quarter. Turning to the balance sheet, we ended the quarter with cash and cash equivalents of $66.6 million and total debt of $34.4 million. As a reminder, this debt represents a financing of construction at our corporate headquarters. Construction of our fourth building continues to go well and according to schedule. Cash from operations was $37.1 million for the third quarter, reflecting our strong revenue performance and the profitability of our business model. The average daily balance of funds held on behalf of clients was approximately $740 million in the third quarter of 2017. Now, let me turn to guidance for the fourth quarter and full year for fiscal 2017. For the fourth quarter of 2017, we expect total revenues in the range of $111.5 million to $113.5 million, representing a growth rate over the comparable prior year period of approximately 28% at the midpoint of the range. We expect adjusted EBITDA for the fourth quarter in the range of $26 million to $28 million, representing an adjusted EBITDA margin of approximately 24% at the midpoint of the range. For fiscal 2017, we are increasing our revenue guidance to a range of $430.5 million to $432.5 million or approximately 31% year-over-year growth at the midpoint of the range. We’re increasing our full year 2017 adjusted EBITDA guidance to a range of a $131 million to a $133 million, representing an adjusted EBITDA margin of approximately 31% at the midpoint of the range. With that, we will open the line for questions. Operator?